Cart
sales@molnova.com
RG 14620
CAS No. 136831-49-7
RG 14620( RG 14620 | TYRPHOSTIN RG 14620. )
Catalog No. M17976 CAS No. 136831-49-7
RG14620 is an epidermal growth factor receptor (EGFR) inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 30 | In Stock |
|
| 5MG | 29 | In Stock |
|
| 10MG | 40 | In Stock |
|
| 25MG | 79 | In Stock |
|
| 50MG | 152 | In Stock |
|
| 100MG | 254 | In Stock |
|
| 200MG | 361 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRG 14620
-
NoteResearch use only, not for human use.
-
Brief DescriptionRG14620 is an epidermal growth factor receptor (EGFR) inhibitor.
-
DescriptionRG-14620 is an EGFR inhibitor. It is a non-phenolic tyrphostin analog, which is selective for the EGF receptor and long acting. It inhibits EGF-stimulated HER14 cell proliferation (IC50=3 μM) as well as tumor growth in vivo.
-
In VitroRG14620 inhibits colony formation (IC50=3 μM) and DNA synthesis (IC50=1 μM) by HER 14 cells, which are stimulated by 50 ng/mL EGF, in a dose-dependent manner. RG14620 also suppresses colony formation(IC50=4 μM) and DNA synthesis (IC50=1.25 μM) by EGF-stimulated MH-85 cells in a dose-dependent manner. The growth-inhibitory effect of RG14620 irreversible.
-
In VivoRG14620, at a dose of 200 g/mouse/day inhibits H-85 tumor growth in nude mice. Mice show less cachexia and hypercalcemia, eat more food, and are more active than untreated MH-85 tumor-bearing animals.
-
SynonymsRG 14620 | TYRPHOSTIN RG 14620.
-
PathwayOthers
-
TargetOther Targets
-
RecptorHER14 colony formation| HER14 DNA synthesis
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number136831-49-7
-
Formula Weight275.13
-
Molecular FormulaC14H8Cl2N2
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 26 mg/mL; 94.50 mM
-
SMILESc1cc(cnc1)/C(=C\c1cc(cc(c1)Cl)Cl)/C#N
-
Chemical Name(E)-3-(3,5-dichlorophenyl)-2-(pyridin-3-yl)acrylonitrile
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yoneda T,et al. Cancer Res. 1991 Aug 15;51(16):4430-5.
molnova catalog
related products
-
2,3-epoxy-N-methylat...
2',3'-epoxy-N-methylatanine
-
(Tyr38,Phe42·46)-Ost...
YQEAFRRFFGPV is a short peptide sequence containing 12 amino acid residues with some emulsification ability
-
Atracurium besylate
Atracurium besylate is a non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alternate non-depolarizing neuromuscular blocking agents.
